Ergosterol Alleviates Kidney Injury in Streptozotocin-Induced Diabetic Mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Ang, Li ^a   Yuguang, Liu ^a   Liying, Wang ^a   Shuying, Zhang ^a   Liting, Xu ^a   Shumin, Wang ^a  

^a CHANGCHUN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CHOLESTEROL; CREATININE; ERGOSTEROL; GLUCOSE; I KAPPA B ALPHA; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLAVICEPS PURPUREA; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; URIC ACID BLOOD LEVEL; WESTERN BLOTTING;

EID: 84948782401     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/691594     Document Type: Article

References (36)

1. J. Perkowski, T. Basiński, M. Wiwart, M. Kostecki, M. Bus̈ko, and A. Matysiak, "The effect of environmental conditions on ergosterol and trichothecene content of naturally contaminated oat grain," Annals of Agricultural and Environmental Medicine, vol. 15, no. 2, pp. 271-276, 2008.
2. A. Gil-Ramírez, V. Caz, R. Martin-Hernandez et al., "Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus," European Journal of Nutrition, 2015.
3. K. Leiva, N. Werner, D. Sepúlveda et al., "Identification and functional characterization of the CYP51 gene from the yeast Xanthophyllomyces dendrorhous that is involved in ergosterol biosynthesis," BMC Microbiology, vol. 15, article 89, 2015.
4. P.-L. Cai, X.-P. He, N. Liu, and B.-R. Zhang, "Effect of overexpression of sterol C-22 desaturase on ergosterol production in yeast strains," Wei Sheng Wu Xue Bao, vol. 47, no. 2, pp. 274-279, 2007.
5. H. Wiseman, "Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action," FEBS Letters, vol. 326, no. 1-3, pp. 285-288, 1993.
6. M. S. Newman, T. R. Brandon, M.N. Groves, W. L. Gregory, S. Kapur, and D. T. Zava, "A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening," Journal of Diabetes Science and Technology, vol. 3, no. 1, pp. 156-162, 2009.
7. E. Yousefi Rad, M. Djalali, F. Koohdani et al., "The effects of vitamin D supplementation on glucose control and insulin resistance in patients with diabetes type 2: a randomized clinical trial study," Iranian Journal of Public Health, vol. 43, no. 12, pp. 1651-1656, 2014.
8. K. A. S. Al-Shoumer and T.M. Al-Essa, "Is there a relationship between vitamin D with insulin resistance and diabetes mellitus?" World Journal of Diabetes, vol. 6, no. 8, pp. 1057-1064, 2015.
9. C. Qian, C. Zhu, W. Yu, X. Jiang, F. Zhang, and L. Malaval, "High-fat diet/low-dose streptozotocin-induced type 2 diabetes in rats impacts osteogenesis and Wnt signaling in bone marrow stromal cells," PLoS ONE, vol. 10, no. 8, Article ID e0136390, 2015.
10. American Diabetes Association, "Diagnosis and classification of diabetes mellitus," Diabetes Care, vol. 33, supplement 1, pp. S62-S69, 2009.
11. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 6th edition, 2014.
12. J. M. Chehade, M. Gladysz, and A. D. Mooradian, "Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management," Drugs, vol. 73, no. 4, pp. 327-339, 2013.
13. R. Schmatz, L. B. Perreira, N. Stefanello et al., "Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats," Biochimie, vol. 94, no. 2, pp. 374-383, 2012.
14. I. Cordero-Herrera, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, "Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells," Molecular Nutrition and Food Research, vol. 57, no. 6, pp. 974-985, 2013.
15. R. K. Avramoglu, H. Basciano, and K. Adeli, "Lipid and lipoprotein dysregulation in insulin resistant states," Clinica Chimica Acta, vol. 368, no. 1-2, pp. 1-19, 2006.
16. M. Z. Mehdi, G. Vardatsikos, S. K. Pandey, and A. K. Srivastava, "Involvement of insulin-like growth factor type 1 receptor and protein kinase Cδ in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells," Biochemistry, vol. 45, no. 38, pp. 11605-11615, 2006.
17. X. Guo, H. Yoshitomi, M. Gao et al., "Guava leaf extracts promote glucose metabolism in SHRSP.Z-Leprfa/Izm rats by improving insulin resistance in skeletal muscle," BMC Complementary and Alternative Medicine, vol. 13, article 52, 2013.
18. C. J. Bailey and C. Day, "Traditional plant medicines as treatments for diabetes," Diabetes Care, vol. 12, no. 8, pp. 553-564, 1989.
19. B. de Courten, A. Mousa, N. Naderpoor, H. Teede, M. P. de Courten, and R. Scragg, "Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial," Trials, vol. 16, article 335, 2015.
20. N. Tsugawa, T. Okano, A. Takeuchi, M. Kayama, and T. Kobayashi, "Metabolism of orally administered ergosterol and 7-dehydrocholesterol in rats and lack of evidence for their vitamin D biological activity," Journal of Nutritional Science and Vitaminology, vol. 38, no. 1, pp. 15-25, 1992.
21. B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry, "Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARγ agonists," The American Journal of Physiology-Endocrinology and Metabolism, vol. 289, no. 1, pp. E151-E159, 2005.
22. G. Saravanan and P. Ponmurugan, "Ameliorative potential of Sallylcysteine: effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes," Experimental and Toxicologic Pathology, vol. 64, no. 6, pp. 639-644, 2012.
23. Y. Yang, D. M. Zhang, J. H. Liu et al., "Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice," Journal of Ethnopharmacology, vol. 169, pp. 49-59, 2015.
24. G. Bayramoglu, H. Senturk, A. Bayramoglu et al., "Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats," Cytotechnology, vol. 66, no. 2, pp. 251-257, 2014.
25. S.-W. Hahm, J. Park, and Y.-S. Son, "Opuntia humifusa stems lower blood glucose and cholesterol levels in streptozotocin-induced diabetic rats," Nutrition Research, vol. 31, no. 6, pp. 479-487, 2011.
26. Z. Deng, Y. Gu, X. Hou et al., "Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study," Diabetes/Metabolism Research and Reviews, 2015.
27. M.-X. Wang, Y.-L. Liu, Y. Yang, D.-M. Zhang, and L.-D. Kong, "Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice," European Journal of Pharmacology, vol. 747, pp. 59-70, 2015.
28. W.-D. Li, K.-F. Fu, G.-M. Li et al., "Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetesmellitus," World Journal of Gastroenterology, vol. 21, no. 32, pp. 9607-9613, 2015.
29. S. Jiang, D. Ren, J. Li et al., "Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus," Fitoterapia, vol. 95, pp. 58-64, 2014.
30. P. M. P. Vareda, L. L. Saldanha, N. A. D. P. Camaforte, N. M. Violato, A. L. Dokkedal, and J. R. Bosqueiro, "Myrcia bella leaf extract presents hypoglycemic activity via PI3k/Akt insulin signaling pathway," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 543606, 10 pages, 2014.
31. G. D. Holman and M. Kasuga, "From receptor to transporter: insulin signalling to glucose transport," Diabetologia, vol. 40, no. 9, pp. 991-1003, 1997.
32. L.-Y. Wang, Y. Wang, D.-S. Xu, K.-F. Ruan, Y. Feng, and S. Wang, "MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model," Journal of Ethnopharmacology, vol. 143, no. 1, pp. 347-354, 2012.
33. H. He, X. Chang, J. Gao, L. Zhu, M. Miao, and T. Yan, "Salidroside mitigates sepsis-induced myocarditis in rats by regulating IGF-1/PI3K/Akt/GSK-3β signaling," Inflammation, vol. 38, no. 6, pp. 2178-2184, 2015.
34. M. F. El-Refaei, S. H. Abduljawad, and A. H. Alghamdi, "Alternative medicine in diabetes-role of angiogenesis, oxidative stress, and chronic inflammation," The Review of Diabetic Studies, vol. 11, no. 3-4, pp. 231-244, 2014.
35. T. Chen, Y. Mou, J. Tan et al., "The protective effect of CDDOMe on lipopolysaccharide-induced acute lung injury in mice," International Immunopharmacology, vol. 25, no. 1, pp. 55-64, 2015.
36. C. Ma, L. Zhu, J. Wang et al., "Anti-inflammatory effects of water extract of Taraxacum mongolicum hand.-Mazz on lipopolysaccharide-induced inflammation in acute lung injury by suppressing PI3K/Akt/mTOR signaling pathway," Journal of Ethnopharmacology, vol. 168, pp. 349-355, 2015.